chronic hepatits B

Why Arbutus Biopharma stock plunged Tuesday
Benzinga
Wed, 04/26/23 - 10:04 am
Arbutus BioPharma
AB-101
FDA
chronic hepatits B
Aligos Therapeutics, developing several different hep B and NASH treatments, files for $100M IPO raise
Endpoints
Mon, 09/28/20 - 10:46 am
IPOs
Algios Therapeutics
NASH
chronic hepatits B